Holuka Eugene Myron
Reporting owner on Forms 3, 4 and 5, CIK 1678292.
Holuka Eugene Myron reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-13.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CTOR · CITIUS ONCOLOGY, INC.CIK 1851484 | director | 1 | 2026-11-13 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CTOR · CITIUS ONCOLOGY, INC.Common Stock, holding | 300,000 | Form 4 | ||||
| CTOR · CITIUS ONCOLOGY, INC.Stock Option (Right to Buy), derivative | 2026-11-12 | A granted | +125,000 | $0 | 125,000 | Form 4 |
| CTOR · CITIUS ONCOLOGY, INC.Stock Option (Right to Buy), derivative, holding | 125,000 | Form 4 | ||||
| CTOR · CITIUS ONCOLOGY, INC.Stock Option (Right to Buy), derivative, holding | 150,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001213900-26-119782 | CITIUS ONCOLOGY, INC. | 2026-11-13 |